Aveni Foundation
- Assets
- $381.9k
- Revenue
- $708.7k
- Investments
- $0.0
- Employees
- 0
- Location
- Santa Monica, CA
- Founding
- 03/2019
- Data as of
- 12/2023
- EIN
- 83-0731767
Organization Overview
Aveni Foundation is located in Santa Monica, CA. The organization was established in 2019. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Aveni Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Aveni Foundation generated $708.7k in total revenue. All expenses for the organization totaled $471.7k during the year ending 12/2023.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE AVENI FOUNDATION IS COMMITTED TO EXPEDITING DEVELOPMENT OF GENE-TARGETED THERAPIES FOR METASTATIC CANCERS AND OTHER UNMET MEDICAL NEEDS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE AVENI FOUNDATION REPORTED THE PERFORMANCE OF TWO CLINICAL STUDIES:1. COMPASSIONATE USE OF INTRAVENOUS DELTAREX-G TUMOR-TARGETED RETROVECTOR BEARING A CYTOCIDAL DOMINANT NEGATIVE CYCLIN G1 INHIBITOR FOR ADVANCED SARCOMA, PANCREATIC CANCER, NON-SMALL CELL LUNG CANCER, BREAST CANCER, CHOLANGIOCARCINOMA, BASAL CELL CARCINOMA (SINGLE USE INDS)2. BLESSED: EXPANDED ACCESS FOR DELTAREX-G FOR ADVANCED PANCREATIC CANCER, SARCOMA AND CARCINOMA OF BREAST FOR AN INTERMEDIATE SIZE POPULATION (NCT04091295)TWENTY-THREE PATIENTS WERE ENROLLED, 13 SARCOMA, 3 PANCREATIC ADENOCARCINOMA, 1 NON-SMALL CELL LUNG CANCER, 3 BREAST CARCINOMA, 1 PROSTATE CANCER, 1 CHOLANGIOCARCINOMA AND 1 BASAL CELL CARCINOMA. FIFTEEN PATIENTS WERE ENROLLED IN STUDY 1 SINGLE PATIENT IND, 8 PATIENTS WERE ENROLLED IN STUDY 2. THREE PATIENTS WERE INITIALLY ENROLLED IN STUDY 2, AND LATER ENROLLED IN STUDY 1. EIGHTEEN OF 23 ENROLLED PATIENTS WERE TREATED WITH DELTAREX-G MONOTHERAPY OR IN COMBINATION WITH FDA APPROVED CANCER THERAPIES. EIGHT OF 18 (44.4%; RANGE 3-47 MONTHS) DELTAREX-G TREATED PATIENTS ARE ALIVE, 2 WITH BREAST CANCER ARE ALIVE IN COMPLETE REMISSION, 1 WITH BREAST CANCER WITH PARTIAL RESPONSE, 3 WITH SARCOMA ARE ALIVE WITH STABLE DISEASE, 1 WITH BASAL CELL CARCINOMA IS ALIVE WITH PARTIAL RESPONSE AND 1 WITH PANCREATIC ADENOCARCINOMA IS ALIVE WITH STABLE DISEASE. THREE PATIENTS DIED OF PROGRESSIVE DISEASE BEFORE RECEIVING DELTAREX-G. TWO PATIENTS WITHDREW WITHOUT RECEIVING DELTAREX-G.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Erlinda Gordon President | OfficerTrustee | 20 | $0 |
Mark Masters Treasurer | OfficerTrustee | 0.5 | $0 |
Marce Mckinnon Secretary | OfficerTrustee | 0.5 | $0 |
Lance Ostendorf Vice Chair | OfficerTrustee | 0.5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $708,683 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $708,683 |
| Total Program Service Revenue | $0 |
| Investment income | $4 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $708,687 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $11,615 |
| Fees for services: Accounting | $7,178 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $6,858 |
| Office expenses | $123 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $782 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $16,152 |
| All other expenses | $36,030 |
| Total functional expenses | $471,672 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $381,884 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $381,884 |
| Accounts payable and accrued expenses | $274 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $274 |
| Net assets without donor restrictions | $381,610 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $381,884 |